Clinical Trials Directory

Trials / Completed

CompletedNCT00853775

Family Research Study: Metabolism of Fats and Proteins in Specific Ethnic Groups

Regulation of Lipoprotein(a) Metabolism in Humans With Reference to Ethnicity

Status
Completed
Phase
Study type
Observational
Enrollment
325 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether lipoprotein(a), also called Lp(a), is a risk factor for cardiovascular (heart) disease. Lipoproteins are tiny particles that circulate in the blood. They contain cholesterol, fat, and protein in varying amounts depending on the body's need. Higher levels of lipoproteins in the blood can cause an increased risk of heart disease. The investigators believe that by studying the Lp(a) lipoprotein in Caucasians and African Americans, the investigators can assess for genetic variation factors related to cardiovascular (heart) disease. The investigators will be looking at 100 African-American families and 100 Caucasian families to confirm whether a higher Lp(a) level is an indicator of a higher risk for heart disease.

Detailed description

During the study visit the research staff will ask about the medical history, perform a brief physical exam, and draw approximately 4 teaspoons of blood of each family member.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention, observational study

Timeline

Start date
2009-02-01
Primary completion
2012-05-01
Completion
2012-12-01
First posted
2009-03-02
Last updated
2017-05-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00853775. Inclusion in this directory is not an endorsement.